AMR 1 data	Detailed identification and antibiotic susceptibility data of specific bacterial isolates, along with unique identifiers, specimen, origin, date of sampling, and demographic data from surveillance sites’ microbiology laboratory records.
Origin	Place: “Hospital” or “Community” origin.
Timeliness of data	AMR data, for a particular month, received within the 15th working day of the following month.
Duplicate data	AMR data occurring within a month i.e., repeated isolates of the same bacterial species isolated from a patient within thirty days, regardless of specimen type.
Specimen–pathogen combination	Combination of priority specimens (namely, blood, urine, stool, or genital swabs) with priority pathogens according to the GLASS2.
Pathogen–antibacterial combination	Combination of eight priority pathogens and the relevant listed antibiotics according to the GLASS.
Consistency of data	Data is considered consistent when the variables used to generate the report are as directed by the GLASS manual i.e., four priority specimens and eight priority pathogens.
Completeness of data	Completeness signifies no missing variables required according to GLASS criteria: age, sex, pathogen, origin, specimen, antibiotic susceptibility results, and date.
Non-reporting sites	The surveillance sites that have not sent any AMR laboratory data to the NPHL3 for ninety days consecutively.
Basic infrastructure	Basic facilities and equipment required by the AMR surveillance site to send the AMR reports to the NPHL.
Specific requirements	Requirements other than the basic infrastructure to send the AMR reports regularly to the NPHL.